The test of your character is what it takes to stop you!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PAOG - adding new locations & waiting for PRs, this one can break copper & more revs to come.
Immuno-oncology, one of the pillars of cancer treatment, is driving engagement worldwide among biotech, large pharma, universities/cancer centers and the financial investment community. Currently, more than 130 biotech and 20 pharma companies are developing immuno-oncology therapies and GT Biopharma is one of a leading pharma company! $GTBP
The economic impact of cancer is significant and is increasing. The total annual economic cost of cancer in 2015 was estimated at approximately US$ 2.5 trillion...Although the economic burden of each cancer case in the United States, the United Kingdom, and Japan ranges between $183-$460 per patient every year, in South America, India, and China it ranges a paltry $0.54-$7.92 per patient. Overall, high-income regions spend 5-10 times more on cancer control on a per capita basis than low- and middle-income countries.
There'a massive opportunity here in $GTBP
I'm hoping for the same. I like to see a continuation of last weeks consistent volume for GTBP
Hello $GTBP friends....
That's where my focus is. GTBP has had consistent volume this week so there is NO reason we can see a solid push next week...
For newbie:
Volume = Trading activity.
Basically:
High volume = Above average # of shares traded
Low volume = Below average # of shares traded.
Immuno-oncology is the next big thing for big pharma! Now, biopharmaceutical companies such as $GTBP are making dramatic advances in an emerging area of research known as immuno-oncology. This marks a significant milestone in the battle against cancer. As the name implies, immuno-oncology marshals the human body’s own immune system to fight cancer. In many cases, immunotherapy is vastly preferable to conventional treatments. Survival rates are higher in several tumor types, and these medications have the potential to significantly extend lives. Treatments also can be deployed against a wide array of cancers. I believe immuno-oncology holds enormous promise for patients and significant opportunities for investors.
With that new management jumping on board, they offers tons of experience being involved with huge biotech companies before GTBP. This company offers value and gettin confidence from new investor as well
$GTBP
Investor Relations:
https://ir.gtbiopharma.com/
Company Profile
https://www.otcmarkets.com/stock/GTBP/profile …
Website:
https://www.gtbiopharma.com/
#Biotechs #Smallcaps #OTCQB #Stockmarket #Biopharma #Pennystocks
#Stockcharts
Almost a 40% bounce on this week, solid executive team additions and promotions . Can it be bouncing in price towards the 1.80s again next week?
With biotechs popping into Momentum movements last 7 days. GTBP is following right along side. Please don't miss the cheaper entries at 1.50s.
Pleasure is mine!!!!
$GTBP have been strong the past few days, perhaps investors have a high degree of confidence in the upcoming financial sector earning reports and indirectly benefitting the healthcare sector, particularly the biotech sub-sector. Keeping my eyes peeled, GTBP for next week...
$GTBP They have hired an All-star board with members from the likes of Pfizer, Mylan, Sanofi, and much more one All-star Avengers has competent and highly experienced in their field NOW work with $GTBP.
Excellent elaboration!!!
thanks for the info, very impressive. I like where this company is heading!!!
Agree! I don't think GTBP can stay down here much longer with this type of volume. Just my opinion. I would really like to see some updates on their trials though.
Considering the company will begin stage 2 of clinical trials on its motion sickness treatment soon, it is easy to imagine the stock being north of $2 within the next few weeks
GT Biopharma’s pipeline of therapies have attracted several industry heavyweights that hail from companies like Pfizer (PFE), Chase Pharmaceuticals, Sanofi (SNY), and Deutsche Bank (DB). GT Biopharma’s pipeline includes numerous treatments in or about to be in Phase II trials as well as other treatments in preclinical trials.
Agree! In fact $ADAC's military contract with the U.S. Government, the company is manufacturing landing gear components for the F-15 for the United States Air Force, valued just over $200,000 in 2016. Great achievement
A Pentagon budget like none before: $700 billion. https://www.foxbusiness.com/markets/a-pentagon-budget-like-none-before-700-billion It's the biggest budget the Pentagon has ever seen: $700 billion. That's far more in defense spending than America's two nearest competitors, China and Russia, and will mean the military can foot the bill for thousands more troops, more training, more ships and a lot else.
Great OPPORTUNITY for $ADAC here.
$GTBP This alone is worth the investment at this price! If GT achieves success, their products/company could be an attractive buy for large pharmaceutical companies.
https://seekingalpha.com/article/4165690-consider-gt-biopharma-future?source=tweet …
$GTBP on the move. At these levels, I feel as though this could be a solid bounce trade at the very least #biotech stocks can quickly jump with a little catalyst
Immuno Oncology is to cancer what smart bombs are to terrorists. It drops a Hellfire missile in the bad guy's lap without damaging the school next door. No collateral damage. The therapy can be calibrated to go only after the cancer cells or cancer stem cells, without damaging healthy cells. It can harness the bodies own "killer cells" to go after cancer cells and deliver deadly "payloads" to those malignant cells alone. This is a huge win not only against cancer, but for the dignity and quality of human life in the midst of medical treatment. It is not just a medicine, it is a victory for humanity.
Good morning everyone!!!
look at the $GTBP chart, it's back in a great position for another bounce
I feel it's a matter of breaking through the 1.80 level and even though volume's been strong, I think another above average day to the upside will be a nice catalyst for another move.
Nice article, I think there's a good shot for long term potential here. Consider What GT Biopharma Could Be In The Future.
http://en.hnosc.com/?gclid=EAIaIQobChMIpofokszs2gIVRhJoCh39sggFEAEYASAAEgJMr_D_BwE
1.74>> This is the best time to BUY. Be a value investor. $GTBP
or you can say Immuno Oncology is to traditional chemo what BITCOIN was to banks and western union: the future has arrived. HODL $GTBP
What other bullish Indicators do you see? ?? $GTBP ??chart is aggressively bullish imo! This could get nutty https://medium.com/stock-market-source/3-biotech-stocks-that-are-trending-this-week-294df995a25 … #biotechnology #technology #oncology #totalpackage #beastmode #hashtag lol WOOOO!
OXS-3550 for liquid tumors. The TRiKE platform has shown promising in vivo data compared to
BiKEs . (The addition of Il-15 created NK cell proliferation resulting in 60-70% remission vs 30-
50% for BiKE)
OXS-4550 Again using the TRiKE platform In Vivo data isn't yet, however Dr. Miller assured me in
the email that they've made significant progress with it.
OXS-4235 There's a chance (albeit slim) that this Multiple Myeloma drugs enters the clinic this
year
$GTBP profit taking is all good, especially after 50% surge, gives new blood a nice entry & keeps a chart healthy.
$GTBP, one of the most overvalued OTC plays out there. Low volume but the company manufactured >$90.212 Million of market cap with an acquisition that was nearly all goodwill.
$GTBP is One of Top 3 Biggest Biotech Stock Movers In Early Second Quarter
https://medium.com/stock-market-source/top-3-biggest-biotech-stock-movers-in-early-second-quarter-c14458909e2f
Biotech is on fire today: $GTBP